Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Numerous reports on microRNAs have illustrated their role in tumor growth and metastasis. Recently, a new prognostic factor, miR‐125b‐2‐3p, has been identified for predicting chemotherapeutic sensitivity in advanced colorectal cancer (CRC). However, the specific mechanisms and biological functions of miR‐125b‐2‐3p in advanced CRC under chemotherapy have yet to be elucidated.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>MiR‐125b‐2‐3p expression was detected by real‐time PCR (RT‐PCR) in CRC tissues. The effects of miR‐125b‐2‐3p on the growth, metastasis, and drug sensitivity of CRC cells were tested in vitro and in vivo. Based on multiple databases, the upstream competitive endogenous RNAs (ceRNAs) and the downstream genes for miR‐125b‐2‐3p were predicted by bioinformatic analysis, followed by the experiments including luciferase reporter assays, western blot assays, and so on.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>MiR‐125b‐2‐3p was significantly lowly expressed in the tissues and cell lines of CRC. Higher expression of miR‐125b‐2‐3p was associated with relatively lower proliferation rates and fewer metastases. Moreover, overexpressed miR‐125b‐2‐3p remarkably improved chemotherapeutic sensitivity of CRC in vivo and in vitro. Mechanistically, miR‐125b‐2‐3p was absorbed by long noncoding RNA (lncRNA) XIST regulating WEE1 G2 checkpoint kinase (WEE1) expression. The upregulation of miR‐125b‐2‐3p inhibited the proliferation and epithelial‐mesenchymal transition (EMT) of CRC induced by lncRNA XIST.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Lower miR‐125b‐2‐3p expression resulted in lower sensitivity of CRC to chemotherapy and was correlated with poorer survival of CRC patients. LncRNA XIST promoted CRC metastasis acting as a ceRNA for miR‐125b‐2‐3p to mediate WEE1 expression. LncRNA XIST‐miR‐125b‐2‐3p‐WEE1 axis not only regulated CRC growth and metastasis but also contributed to chemotherapeutic resistance to CRC.</p></section>

WITHDRAWN: the LncRNA XIST Promotes Colorectal Cancer Cell Growth Through Regulating Mir-497-5p/foxk1 Axis

SP1-induced Lncrna TINCR Overexpression Contributes to Colorectal Cancer Progression by Sponging Mir-7-5p

Long Noncoding RNA XIST Expedites Metastasis and Modulates Epithelial–mesenchymal Transition in Colorectal Cancer

LncRNA XIST acts as a ceRNA sponging miR-185-5p to modulate pancreatic cancer cell proliferation via targeting CCND2

Knockdown Of Lncrna-Xist Suppresses Proliferation And Tgf-Beta 1-Induced Emt In Nsclc Through The Notch-1 Pathway By Regulation Of Mir-137

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

The role of XBP-1-mediated unfolded protein response in colorectal cancer progression-a regulatory mechanism associated with lncRNA-miRNA-mRNA network

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

LncRNA XIST Promotes Liver Cancer Progression by Acting As a Molecular Sponge of Mir-200B-3p to Regulate ZEB1/2 Expression

LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression

Lncrna XIST Regulates Proliferation and Migration of Hepatocellular Carcinoma Cells by Acting As Mir-497-5p Molecular Sponge and Targeting PDCD4

Long Noncoding RNA XIST Regulates the EGF Receptor to Promote TGF-β1-induced Epithelial–mesenchymal Transition in Pancreatic Cancer

Lncrna Xist Acts As A Tumor Suppressor In Prostate Cancer Through Sponging Mir-23a To Modulate Rkip Expression

Long Non-Coding Rna Xist Promotes Cell Growth And Metastasis Through Regulating Mir-139-5p Mediated Wnt/Beta-Catenin Signaling Pathway In Bladder Cancer

The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer

Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion

The Lncrna XIST Regulates the Tumorigenicity of Renal Cell Carcinoma Cells Via the Mir-302C/sdc1 Axis

Long Noncoding RNA FOXD3‐AS1 Promotes Colon Adenocarcinoma Progression and Functions As a Competing Endogenous RNA to Regulate SIRT1 by Sponging Mir‐135a‐5p

Long Noncoding RNA LINC00460 Facilitates Colorectal Cancer Progression by Negatively Regulating miR-613

Downregulation of LINC00958 Inhibits Proliferation, Invasion and Migration, and Promotes Apoptosis of Colorectal Cancer Cells by Targeting Mir‑3619‑5p

Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1